APA (7th ed.) Citation

JD, S., C, K., M, R., RD, N., Z, W., M, S., . . . K, I. (2023). ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment. Cell reports, 42(6), 112665. https://doi.org/10.1016/j.celrep.2023.112665

Chicago Style (17th ed.) Citation

JD, Steimle, et al. "ETV2 Primes Hematoendothelial Gene Enhancers Prior to Hematoendothelial Fate Commitment." Cell Reports 42, no. 6 (2023): 112665. https://doi.org/10.1016/j.celrep.2023.112665.

MLA (9th ed.) Citation

JD, Steimle, et al. "ETV2 Primes Hematoendothelial Gene Enhancers Prior to Hematoendothelial Fate Commitment." Cell Reports, vol. 42, no. 6, 2023, p. 112665, https://doi.org/10.1016/j.celrep.2023.112665.